Remics: a redescription-based framework for multi-omics analysis

Complex diseases such as cancer are characterized by their intricate etiology, arising from several molecular mechanisms that span multiple omic layers. To obtain insights on disease subtypes, associated biomarkers, and improve prognostic modeling, it is essential to integrate and interpret multi-omics data in a biologically meaningful way. We introduce Remics, a redescription-based framework for multi-omics integration inspired by higher-order statistical representations. Remics leverages higher-order cumulants to identify redescriptions, which are sets of multi-omics features that jointly capture equivalent biological variation across modalities. These feature groups are further analyzed through network representations, multi-omics risk scoring, and biomarker discovery to reveal molecular interactions underlying disease mechanisms. We applied Remics on simulated data as well as multi-omics data of six different cancer types from The Cancer Genome Atlas. We demonstrate that redescription-based integration uncovers functionally coherent cross-omics feature associations and compare them with state-of-the-art approaches. Our results highlight the potential of higher-order multi-omics statistical analysis to advance precision medicine through improved interpretability and discovery of novel molecular relationships.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-03-04
DOI
https://doi.org/10.3389/fcell.2026.1738010
Primary Topic
Bioinformatics and Genomic Networks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Remics: a redescription-based framework for multi-omics analysis

Aritra Bose, Myson Burch, Niina Haiminen, Aldo Guzmán-Sáenz et al.
Frontiers in Cell and Developmental Biology
Bioinformatics and Genomic Networks
article

Remics: a redescription-based framework for multi-omics analysis

Aritra Bose, Myson Burch, Niina Haiminen, Aldo Guzmán-Sáenz, Daniel E. Platt, Laxmi Parida
article en

Abstract

Complex diseases such as cancer are characterized by their intricate etiology, arising from several molecular mechanisms that span multiple omic layers. To obtain insights on disease subtypes, associated biomarkers, and improve prognostic modeling, it is essential to integrate and interpret multi-omics data in a biologically meaningful way. We introduce Remics, a redescription-based framework for multi-omics integration inspired by higher-order statistical representations. Remics leverages higher-order cumulants to identify redescriptions, which are sets of multi-omics features that jointly capture equivalent biological variation across modalities. These feature groups are further analyzed through network representations, multi-omics risk scoring, and biomarker discovery to reveal molecular interactions underlying disease mechanisms. We applied Remics on simulated data as well as multi-omics data of six different cancer types from The Cancer Genome Atlas. We demonstrate that redescription-based integration uncovers functionally coherent cross-omics feature associations and compare them with state-of-the-art approaches. Our results highlight the potential of higher-order multi-omics statistical analysis to advance precision medicine through improved interpretability and discovery of novel molecular relationships.

Frontiers in Cell and Developmental BiologyVol. 14
Research Studios Austria (AT)
Openalex Percentile: Top 34%
Bioinformatics and Genomic Networks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.